The Journal of Practical Medicine >
Prognosis and immune correlation analysis of m1A/m5C/m6A/m7G regulated genes in gastric cancer
Received date: 2024-01-08
Online published: 2024-05-15
Objective This study aims to develop a prognostic risk prediction model for gastric cancer based on m1A/m5C/m6A/m7G regulated genes and to investigate the relationship between this model and immunology. Methods The Cancer Genome Atlas （TCGA） gastric cancer dataset was utilized to identify m1A/m5C/m6A/m7G regulated genes with significant expression differences. A prognostic risk score （RS） model was constructed using univariate Cox regression analysis and the LASSO algorithm. The RS model was validated using the Kaplan?Meier （K?M） statistic and cell lines for RT?qPCR biological validation. A nomogram model was created using univariate and multivariate Cox regression analyses. The CIBERSORT algorithm and ESTIMATE package were employed to conduct immune correlation analysis. Results A prognostic RS model based on eight methylation regulated genes was developed to classify patients with gastric cancer as high?risk or low?risk. These eight genes showed significant expression in gastric cancer cell lines （P < 0.05）. The TCGA?gastric cancer training set and GSE62254?validation set showed a substantial connection （P < 0.001） between overall survival rate （OS） and grouping status. The nomogram survival models accurately predicted 1?year （C?index = 0.703）， 3?year （C?index = 0.729）， and 5?year （C?index = 0.734） survival rates. Immune correlation analysis showed that compared to the low?risk group， the high?risk group had higher immune scores and higher expression of immune checkpoint?related genes （P < 0.05）. Conclusion We created a reliable prognostic RS model based on m1A/m5C/m6A/m7G regulated genes that can predict gastric cancer prognosis and guide individualized immunotherapy decisions.
Key words： m1A; m5C; m6A; m7G; gastric cancer; prognosis; immune infiltration
Xiaomei CHEN , Anqi WANG , Jizhen YANG , Miao YU . Prognosis and immune correlation analysis of m1A/m5C/m6A/m7G regulated genes in gastric cancer[J]. The Journal of Practical Medicine, 2024 , 40(9) : 1230 -1237 . DOI: 10.3969/j.issn.1006-5725.2024.09.009
| 1 | NACEV B A， JONES K B， INTLEKOFER A M， et al. The epigenomics of sarcoma［J］. Nat Rev Cancer， 2020，20（10）： 608-623. doi:10.1038/s41568-020-0288-4 |
| 2 | SHI H， CHAI P， JIA R， et al. Novel insight into the regulatory roles of diverse RNA modifications： Re-defining the bridge between transcription and translation［J］. Mol Cancer， 2020，19（1）： 78. doi:10.1186/s12943-020-01194-6 |
| 3 | HAN H， YANG C， MA J， et al. N（7）-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis［J］. Nat Commun， 2022，13（1）： 1478. doi:10.1038/s41467-022-29125-7 |
| 4 | LI N， ZENG A， WANG Q， et al. Regulatory function of DNA methylation mediated lncRNAs in gastric cancer［J］. Cancer Cell Int， 2022，22（1）： 227. doi:10.1186/s12935-022-02648-1 |
| 5 | BINNEWIES M， ROBERTS E W， KERSTEN K， et al. Understanding the tumor immune microenvironment （TIME） for effective therapy［J］. Nat Med， 2018，24（5）： 541-550. doi:10.1038/s41591-018-0014-x |
| 6 | XU L， ZOU C， ZHANG S， et al. Reshaping the systemic tumor immune environment （STIE） and tumor immune microenvironment （TIME） to enhance immunotherapy efficacy in solid tumors［J］. J Hematol Oncol， 2022，15（1）： 87. doi:10.1186/s13045-022-01307-2 |
| 7 | LI N， KANG Y， WANG L， et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment［J］. Proc Natl Acad Sci U S A， 2020，117（33）： 20159-20170. doi:10.1073/pnas.1918986117 |
| 8 | OH S C， SOHN B H， CHEONG J H， et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype［J］. Nat Commun， 2018，9（1）： 1777. doi:10.1038/s41467-018-04179-8 |
| 9 | CHEN Y， LIN H， MIAO L， et al. Role of N7-methylguanosine （m7G） in cancer［J］. Trends Cell Biol， 2022，32（10）： 819-824. doi:10.1016/j.tcb.2022.07.001 |
| 10 | LI D， LI K， ZHANG W， et al. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma［J］. Front Immunol， 2022，13： 918140. doi:10.3389/fimmu.2022.918140 |
| 11 | YANG B， WANG J Q， TAN Y， et al. RNA methylation and cancer treatment［J］. Pharmacol Res， 2021，174： 105937. doi:10.1016/j.phrs.2021.105937 |
| 12 | WANG X， TIAN L， LI Y， et al. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent［J］. J Exp Clin Cancer Res， 2021，40（1）： 80. doi:10.1186/s13046-021-01871-4 |
| 13 | CAI X， CHEN Y， MAN D， et al. RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner［J］. Cell Death Discov， 2021，7（1）： 315. doi:10.1038/s41420-021-00703-w |
| 14 | WANG Q， ZHANG Q， HUANG Y， et al. m（1）A Regulator TRMT10C Predicts Poorer Survival and Contributes to Malignant Behavior in Gynecological Cancers［J］. DNA Cell Biol， 2020，39（10）： 1767-1778. doi:10.1089/dna.2020.5624 |
| 15 | ZHANG Q， YAN Y F， LV Q， et al. miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation［J］. Cell Death Dis， 2021，12（8）： 735. doi:10.1038/s41419-021-04021-y |
| 16 | CHEN D， ZHANG R， XIE A， et al. Clinical correlations and prognostic value of Nudix hydroxylase 10 in patients with gastric cancer［J］. Bioengineered， 2021，12（2）： 9779-9789. doi:10.1080/21655979.2021.1995104 |
| 17 | GRISANZIO C， WERNER L， TAKEDA D， et al. Genetic and functional analyses implicate the NUDT11， HNF1B， and SLC22A3 genes in prostate cancer pathogenesis［J］. Proc Natl Acad Sci U S A， 2012，109（28）： 11252-11257. doi:10.1073/pnas.1200853109 |
| 18 | XIA P， ZHANG H， XU K， et al. MYC-targeted WDR4 promotes proliferation， metastasis， and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma［J］. Cell Death Dis， 2021，12（7）： 691. doi:10.1038/s41419-021-03973-5 |
| 19 | LI X Y， WANG S L， CHEN D H， et al. Construction and Validation of a m7G-Related Gene-Based Prognostic Model for Gastric Cancer［J］. Front Oncol， 2022，12： 861412. doi:10.3389/fonc.2022.861412 |
| 20 | YANG S， LIU T， CHENG Y， et al. Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer［J］. Cancer Sci， 2019，110（12）： 3639-3649. doi:10.1111/cas.14216 |
| 21 | XU C， SUI S， SHANG Y， et al. The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma［J］. J Adv Res， 2020，24： 139-148. doi:10.1016/j.jare.2020.03.009 |
| 22 | EISSMANN M F， DIJKSTRA C， JARNICKI A， et al. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization［J］. Nat Commun， 2019，10（1）： 2735. doi:10.1038/s41467-019-10676-1 |
| 23 | LICHTERMAN J N， REDDY S M. Mast Cells： A New Frontier for Cancer Immunotherapy［J］. Cells， 2021，10（6）： 1270. doi:10.3390/cells10061270 |
| 24 | WANG P， WANG H， HUANG Q， et al. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation［J］. Theranostics， 2019，9（6）： 1714-1727. doi:10.7150/thno.30716 |
| 25 | CENDROWICZ E， SAS Z， BREMER E， et al. The Role of Macrophages in Cancer Development and Therapy［J］. Cancers （Basel）， 2021，13（8）： 1946. doi:10.3390/cancers13081946 |
| 26 | YU D， WALKER L， LIU Z， et al. Targeting T（FH） cells in human diseases and vaccination： rationale and practice［J］. Nat Immunol， 2022，23（8）： 1157-1168. doi:10.1038/s41590-022-01253-8 |
| 27 | GONG Z， ZHANG J， GUO W. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer［J］. Cancer Med， 2020，9（23）： 9052-9063. doi:10.1002/cam4.3505 |
| 28 | ZENG D， ZHOU R， YU Y， et al. Gene expression profiles for a prognostic immunoscore in gastric cancer［J］. Br J Surg， 2018，105（10）： 1338-1348. doi:10.1002/bjs.10871 |
/
| 〈 |
|
〉 |